Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Apply
CAR T Cells
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step